Handlekraftig AS is an attempt at doing slightly more for the environment than just sorting trash and buying as little plastic as possible. For now, this is a single organic shop where most products are sold in bulk/lose weight. We encourage our customers to bring in their own containers to shop, to minimize the need for new packaging. We try to keep at least 95% of the consumables organic. This is better for our customers and better for the earth. In addition to organic foodstuff, we also offer a wide selection of zero-waste products, such as beeswax wraps, wooden kitchen utensils, and non-plastic containers.

Otivio’s main product, FlowOx™, is addressing chronic wounds with focus on peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very large and increasing. There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Long-term patient testing in more than 50 patients documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked. In fourth quarter 2017 had its commercial break-through through sales of FlowOx to public customers.

The world’s largest brands use Mevo to motivate, inform and incentivize frontline retail salespeople to sell more and build brand loyalty. Mevo connects brands to external sales teams. A fully branded sales contest app makes sure brands stay top of mind where it counts the most. EDUCATE & MOTIVATE with product training, challenges, contests, and more through sales and training gamification software.

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Nordic Electrofuel offers a solution for the rapid transition from fossil to renewable electrical energy for all transport sectors. It is based on the conversion of renewable electric energy into liquid electro-fuels that can be as easily transported, stored, and used as conventional fossil hydrocarbons. It also provides a good solution to distribute and store stranded electrical energy. PTL (Power To Liquid) has been considered too expensive, but with the low electricity price in Norway and new efficient processing and upgrading solutions, it has become commercially feasible. Electrification of transportation is required to avoid catastrophic climate change. Battery- or cable-electric solutions are not feasible for transport like aviation and long-distance marine transport. Liquid energy carriers such as biofuels are desperately needed but limited. The fuel is free of sulfur and can therefore be used maritime industry as a fuel after 2022. The fuel emits much fewer particles and aromatics than conventional fossil fuel, so it also solves the local pollution problem. Competitive advantages: • Norway’s low electricity price from hydro and lately also wind power. • 20 - 30 % lower electricity consumption than with existing technology • Lower production price than advanced biofuels • Agreements in place for a site at Herøya, which has all utilities (cooling water, cheap renewable electricity, etc.) and processing expertise available. • About the same source to shaft efficiency as hydrogen, but with much lower total CAPEX due to no investment in distribution systems and engines.

AURA Biopharm AS was founded in 2016 by a team of scientists and drug developers with many years of experience in academia and major pharmaceutical companies and a proven track record of success in drug development. The emphasis of AURA is the development of novel and breakthrough therapies for unmet medical needs and orphan diseases and our slogan “A new opportunity for health” reflects AURA's mission to give a new opportunity to diseases in need of new and/or better therapies. The company operates virtually using a network of external collaborators (consultants, KOLs, CROs, CMOs etc).

Zegeba is a software company based in Ålesund, Norway! International enterprises and organizations use our innovative digital data solutions for time-saving and effective collaboration, reporting, and data capture. Zegeba is a unified digital solution for all types and sizes of forms, tasks, reports, inspections, multimedia, and data capture in general on apps, mobile, tablet, or web. Zegeba works both online and offline, and thereby empowers happy workers around the world every day! Zegeba Platform is built for easy transformation of human work processes related to documentation work on paper or files requiring manual rework, into an all-digital format that can be used as part of an automated process, and generates reports and data for analysis immediately. All businesses are unique and with Zegeba it is possible to create and design forms, tasks, checklists, and digital reports to suit your needs and core processes. Get control of data, save time, and increase the quality of your data using Zegeba.

MYREZE AS is an international broadcast design company with headquarters in Norway. Our main focus is branding and opening titles for film and TV. Our expertise includes everything from professional music videos to comprehensive corporate rebranding, working relentlessly to deliver outcomes of the highest quality for our clients. Our mission is to develop and brand movies and TV in the most profound and innovative way in order to create a stronger identity targeted toward their respective audiences.

Our vision is to design and operate a “Green High-Security Hyperscale Datacenter” with the lowest PUE (Power Usage Efficiency) in the world.Think BigStart SmallMove Fast. Development of Green High-Security Datacenters, embarking upon groundbreaking environmental and state-of-the-art power usage efficiency technology.

ICT is a Norwegian technology development company that holds patents designed to bring new opportunities to the cryogenic liquids storage and transportation sectors via unique containers. The design targets the market for both large- and small-scale cryogenic applications. ICT’s solution is modular and suited for onshore as well as maritime use. The development of hydrogen infrastructure is slow and holding back widespread adoption. Transportation of large volumes is one of the major challenges that IC Technologies is determined to solve. Another challenge is the storage of liquid hydrogen. Current storage solutions resemble enlarged thermos flasks, and the hydrogen inside gradually evaporates over time. Our vision is a decarbonized world with green hydrogen as a major energy carrier.

"Sammen om en jobb" (Together for a Job) is a Norwegian NGO running a mentor program between young immigrants and elderly Norwegians. The program has three principal aims:- transfer skills and knowledge from elderly people at the end of their professional careers to young immigrants just about to start theirs - provide a meaningful activity for people entering into retirement- support young immigrants in their job search- create relationships between different generations and cultures

Inbound marketing er en av de viktigste trendene innen digital markedsføring. Innen få år vil store deler av næringslivet endre måten de markedsfører seg på.Vi er Norges raskest voksende byrå og ansetter 50 nye medarbeidere de neste 5 årene.Les om hva inbound marketing er her.Inbound Group er Norges første rendyrkede inbound marketing-byrå. Vi er finansielt solide og har eiere med store ambisjoner. Vi skal innen 2020 bli Europas ledende innen inbound marketing.Vår viktigste oppgave er å hjelpe bedrifter med å vokse. Ved bruk av en helhetlig metodikk for hvordan drive digital markedsføring hjelper vi bedrifter å få flere leads og nye kunder. Vi gjør analyser, lager strategi og produserer innhold. Vi fungerer som hele eller deler av bedrifters markedsavdeling.

Vimond provides online streaming software and services for broadcasters and content providers worldwide. Our local team counts 62 people from 17 nations, of which a majority are developers with a strong passion and expertise in online video workflows and innovative software and web development. As we continue to grow our team, we are always looking for people with relevant experience in media technology, software development, product development, system administration & dev ops, tech team lead roles, project management, account management, and solution architect roles. Contact us for an informal chat!

NORIGIN MEDIA is a TV Everywhere company, which enables multi-screen and OTT services for carriers, broadcasters, and content owners. The Scandinavian company offers a complete multi-screen application suite and a Live TV hosting headend capacity as primary products. NORIGIN MEDIA is reinventing how people watch TV. Join the technical revolution on how people will consume TV content in the years to come. You will architect and develop user experiences that will reach millions of TV users on Smartphones, Tablets, PCs, Connected TV, and Game Consoles.